Results From a 12-Month Open-Label Phase 1/2 Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher Disease
Tantawy, Azza A. G., El-Beshlawy, Amal, Marzouk, Iman, Bavdekar, Ashish, Qin, Yulin, Mellgard, Björn, Ben Turkia, HadhamiVolume:
6
Journal:
Journal of Inborn Errors of Metabolism and Screening
DOI:
10.1177/2326409818765564
Date:
January, 2018
File:
PDF, 148 KB
2018